COMMUNIQUÉS West-GlobeNewswire

Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026
28/04/2026
SALT LAKE CITY, April 28, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first quarter 2026 earnings conference call at 4: [...]
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026
28/04/2026
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the [...]
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026
SAN DIEGO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, [...]
EssilorLuxottica: Assemblée générale 2026 d’EssilorLuxottica
28/04/2026
Assemblée générale 2026 d’EssilorLuxottica Toutes les résolutions proposées par le Conseil d’administration adoptées Dividende de 4,00 € par action, avec possibilité de choisir un versement en actions Paris, France (28 [...]
Chaque minute compte : l’EAACI appelle à une action urgente pour garantir à l’école la sécurité des enfants exposés au risque d’anaphylaxie
28/04/2026
Au Spanish Congress of Deputies (Congrès des députés espagnol), María Torres la Présidente de l’EAACI, a apporté son soutien à un manifeste commun rédigé avec l’AEPNAA, la SEAIC et la SEICAP, appelant à une action [...]
Disclosure of transparency notification from BlackRock, Inc.
28/04/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 28 April 2026 – 6 PM CET Disclosure of transparency notification from BlackRock, Inc. Pursuant to the Belgian act of 2 May 2007 on the disclosure of [...]
CORRECTION -- Quoin Pharmaceuticals Provides Clinical and Regulatory Update for QRX009 Topical Rapamycin Development Programs
28/04/2026
Company Planning Multi-Pronged Approach for QRX009 Including Several Investigator Led Clinical Studies in Key Indications. Company to Initiate Investigator Led Clinical Study in Pachyonychia Congenita Study Will be Led [...]
FDA Announces Major Steps to Implement Real-Time Clinical Trials
28/04/2026
Agency unveils real-time trial proofs-of-concept and upcoming pilot program White Oak, Md., April 28, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced two major steps as part of an [...]
EssilorLuxottica: EssilorLuxottica 2026 Annual Shareholders’ Meeting
28/04/2026
EssilorLuxottica 2026 Annual Shareholders’ Meeting All resolutions proposed by the Board of Directors adopted Dividend of Euro 4.00 per share, with option for payment in shares Paris, France (28 April 2026 – 6:00 pm [...]
Alira Health Joins PFMD Effort to Advance Patient-Centered Evidence Generation
28/04/2026
Contribution will support multi-stakeholder efforts to strengthen the use of patient experience data in healthcare decision-making FRAMINGHAM, Mass., April 28, 2026 (GLOBE NEWSWIRE) -- Alira Health today announced its [...]
Clariane annonce le succès de son offre de 230 millions d’euros d’obligations senior additionnelles
28/04/2026
NE PAS DIFFUSER, PUBLIER OU DISTRIBUER, DIRECTEMENT OU INDIRECTEMENT, AUX ÉTATS-UNIS D’AMÉRIQUE, AU CANADA, AU JAPON OU EN AUSTRALIE, OU DANS TOUTE AUTRE JURIDICTION OU IL EST ILLÉGAL DE DIFFUSER, DE PUBLIER OU DE [...]
MiniMed announces Health Canada License for Simplera Sync™ Sensor, Type 2 Diabetes Indication with MiniMed™ 780G System
28/04/2026
Latest authorization expands MiniMed CGM portfolio in Canada BRAMPTON, Ontario, April 28, 2026 (GLOBE NEWSWIRE) -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in insulin delivery, announced Health [...]
The Aesthetic Show Celebrates 19 Years of Innovation, Education, and Excellence in Aesthetic Medicine — Announces Expanded 2026 Event in Las Vegas, June 25 - 28
28/04/2026
LAS VEGAS, April 28, 2026 (GLOBE NEWSWIRE) -- The Aesthetic Show (TAS), one of the most respected and dynamic events in aesthetic medicine, proudly announces its 19th annual gathering this June 25th - 28th, marking [...]
Aeroflow Health Applauds Georgia Medicaid’s New Telehealth Lactation Coverage
28/04/2026
Georgia Medicaid members now have access to telehealth lactation services, following sustained advocacy efforts led by Aeroflow and the American Telemedicine Association ASHEVILLE, N.C., April 28, 2026 (GLOBE NEWSWIRE [...]
Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects and Clinical Improvement in Chronic Insomnia
28/04/2026
Publication reports statistically significant improvement in sleep quality following treatment with Nexalin’s 15 mA, 77.5 Hz stimulation approach, with no meaningful improvement in the sham group Neuroimaging data [...]
BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
28/04/2026
LAS VEGAS, April 28, 2026 (GLOBE NEWSWIRE) -- via IBN — BioAdaptives, Inc. (OTC: BDPT) today announced the official launch of MyndSystem™ and website. MyndSystem™ was originally developed for professional fighters. We [...]
Invitation to the presentation of ALK’s first quarter 2026 results on Tuesday, 5 May 2026
28/04/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) will publish its results for the first quarter of 2026 in the morning on Tuesday, 5 May 2026. Later on the same day, the company will host a presentation for investors and [...]
Clariane announces the success of its offering of €230 million of additional senior notes
28/04/2026
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Clariane [...]
Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026
28/04/2026
Oslo, Norway, 28 April 2026 Vistin Pharma ASA (OSE: VISTN); please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 20 May 2026 at 13:00 CEST. It will not be possible with physical [...]

Pages